217 related articles for article (PubMed ID: 8966311)
1. [Susceptibility to chemotherapeutic agents of Schistosoma mansoni isolates from patients treated with oxamniquine and praziquantel and not cured].
Araújo N; de Souza CP; Passos LK; Simpson AJ; Dias Neto E; Pereira TR; Cerutti Júnior C; de Alencar FE; Dietze R; Katz N
Rev Soc Bras Med Trop; 1996; 29(5):467-76. PubMed ID: 8966311
[TBL] [Abstract][Full Text] [Related]
2. Altered response of strain of Schistosoma mansoni to oxamniquine and praziquantel.
Bonesso-Sabadini PI; de Souza Dias LC
Mem Inst Oswaldo Cruz; 2002 Apr; 97(3):381-5. PubMed ID: 12048569
[TBL] [Abstract][Full Text] [Related]
3. Resistance to oxamniquine of a Schistosoma mansoni strain isolated from patient submitted to repeated treatments.
Coelho PM; Lima e Silva FC; Nogueira-Machado JA
Rev Inst Med Trop Sao Paulo; 1997; 39(2):101-6. PubMed ID: 9394523
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical Investigations of Treatment with Ro 13-3978, Praziquantel, Oxamniquine, and Mefloquine in Schistosoma mansoni-Infected Mice.
Panic G; Ruf MT; Keiser J
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971860
[TBL] [Abstract][Full Text] [Related]
5. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates.
Fallon PG; Mubarak JS; Fookes RE; Niang M; Butterworth AE; Sturrock RF; Doenhoff MJ
Exp Parasitol; 1997 May; 86(1):29-36. PubMed ID: 9149238
[TBL] [Abstract][Full Text] [Related]
6. Association of oxamniquine praziquantel and clonazepam in experimental Schistosomiasis mansoni.
Araujo N; Mattos AC; Coelho PM; Katz N
Mem Inst Oswaldo Cruz; 2008 Dec; 103(8):781-5. PubMed ID: 19148417
[TBL] [Abstract][Full Text] [Related]
7. Temporal differences in praziquantel- and oxamniquine-induced tegumental damage to adult Schistosoma mansoni: implications for drug-antibody synergy.
Fallon PG; Fookes RE; Wharton GA
Parasitology; 1996 Jan; 112 ( Pt 1)():47-58. PubMed ID: 8587801
[TBL] [Abstract][Full Text] [Related]
8. Response of drug resistant isolates of Schistosoma mansoni to antischistosomal agents.
Drescher KM; Rogers EJ; Bruce JI; Katz N; Dias LC; Coles GC
Mem Inst Oswaldo Cruz; 1993; 88(1):89-95. PubMed ID: 8246759
[TBL] [Abstract][Full Text] [Related]
9. Schistosoma mansoni: chemotherapy of infections of different ages.
Sabah AA; Fletcher C; Webbe G; Doenhoff MJ
Exp Parasitol; 1986 Jun; 61(3):294-303. PubMed ID: 3086114
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of alternating therapy with oxamniquine and praziquantel to treat Schistosoma mansoni in children following failure of first treatment.
Katz N; Rocha RS; de Souza CP; Coura Filho P; Bruce JI; Coles GC; Kinoti GK
Am J Trop Med Hyg; 1991 May; 44(5):509-12. PubMed ID: 1905880
[TBL] [Abstract][Full Text] [Related]
11. Activity of oxamniquine at skin, pulmonary and sexual maturation phases, on a Schistosoma mansoni strain (R1) previously reported as resistant at the adult phase.
Coelho PM; Ribeiro F; Mello RT; Lima e Silva FC; Nogueira-Machado JA
Mem Inst Oswaldo Cruz; 1998; 93 Suppl 1():267-8. PubMed ID: 9921366
[No Abstract] [Full Text] [Related]
12. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel.
Ismail M; Metwally A; Farghaly A; Bruce J; Tao LF; Bennett JL
Am J Trop Med Hyg; 1996 Aug; 55(2):214-8. PubMed ID: 8780463
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapeutic effects on larval stages of Schistosoma mansoni during infection and re-infection of mice.
Silva LM; Menezes RM; de Oliveira SA; Andrade ZA
Rev Soc Bras Med Trop; 2003; 36(3):335-41. PubMed ID: 12908033
[TBL] [Abstract][Full Text] [Related]
14. Oxamniquine, praziquantel and lovastatin association in the experimental Schistosomiasis mansoni.
Araújo N; Mattos AC; Sarvel AK; Coelho PM; Katz N
Mem Inst Oswaldo Cruz; 2008 Aug; 103(5):450-4. PubMed ID: 18797757
[TBL] [Abstract][Full Text] [Related]
15. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.
Fallon PG; Doenhoff MJ
Am J Trop Med Hyg; 1994 Jul; 51(1):83-8. PubMed ID: 8059919
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the effect of oxamniquine, praziquantel and a combination of both drugs on the intramolluscan phase of Schistosoma mansoni.
Mattos AC; Pereira GC; Jannotti-Passos LK; Kusel JR; Coelho PM
Acta Trop; 2007 May; 102(2):84-91. PubMed ID: 17498638
[TBL] [Abstract][Full Text] [Related]
17. Experimental chemotherapy of Schistosoma mansoni with praziquantel and oxamniquine: differential effect of single or combined formulations of drugs on various strains and on both sexes of the parasite.
Delgado VS; Suárez DP; Cesari IM; Incani RN
Parasitol Res; 1992; 78(8):648-54. PubMed ID: 1480600
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial.
Ferrari ML; Coelho PM; Antunes CM; Tavares CA; da Cunha AS
Bull World Health Organ; 2003; 81(3):190-6. PubMed ID: 12764515
[TBL] [Abstract][Full Text] [Related]
19. Relationship between schistosomicidal drug efficacy, gonadal steroid hormonal changes and state of disease immunopathology in murine schistosomiasis mansoni.
Botros SS; Salama SH; Estafan MY; Gomaa NE; Metwally AA; Ebeid FA
Pharmacol Res; 1990; 22(3):359-70. PubMed ID: 2114615
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of treatment of murine Schistosoma mansoni infections with praziquantel and oxamniquine correlates with infection intensity: role of host antibody.
Fallon PG; Hamilton JV; Doenhoff MJ
Parasitology; 1995 Jul; 111 ( Pt 1)():59-66. PubMed ID: 7609991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
